Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | STAT3 | P40763 | 1/20 | 0.30 |
| ▸ | PTPRS | Q13332 | 1/20 | 0.30 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21021494 | 0.84 | LMNA (0.33) | KDM4EALDH1A1MAPTLMNAKMT2A | |
| SCHEMBL20650754 | 0.84 | LMNA (0.33) | LMNAKMT2ASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL20172902 | 0.83 | SLC6A4 (0.36) | KDM4EALDH1A1GAAMAPTSLC6A2 | |
| SCHEMBL21020327 | 0.83 | LMNA (0.33) | LMNAKMT2ASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL20650800 | 0.81 | KMT2A (0.33) | LMNAKMT2ASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL21020454 | 0.81 | LMNA (0.32) | ALDH1A1LMNAKMT2ASMN1; SMN2PTPN2 | |
| SCHEMBL21020306 | 0.81 | KMT2A (0.34) | KDM4EALDH1A1MAPTLMNAKMT2A | |
| SCHEMBL21020333 | 0.81 | PTPN2 (0.32) | LMNAKMT2ASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL21020593 | 0.81 | KDM4E (0.39) | KDM4EALDH1A1GAAMAPTSLC6A2 | |
| SCHEMBL21020468 | 0.81 | ALDH1A1 (0.39) | KDM4EALDH1A1GAAMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | KDM4E 517/4885ALDH1A1 1103/4885GAA 2197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.